| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein kinase activator activity | 5.45e-05 | 149 | 89 | 6 | GO:0030295 | |
| GeneOntologyMolecularFunction | kinase activator activity | 7.81e-05 | 159 | 89 | 6 | GO:0019209 | |
| GeneOntologyMolecularFunction | protein kinase regulator activity | 1.59e-04 | 259 | 89 | 7 | GO:0019887 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 4.09e-04 | 78 | 89 | 4 | GO:0043539 | |
| GeneOntologyMolecularFunction | kinase regulator activity | 4.28e-04 | 305 | 89 | 7 | GO:0019207 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 6.45e-04 | 38 | 89 | 3 | GO:0000146 | |
| GeneOntologyMolecularFunction | enzyme activator activity | MYO9A CD33 MOB1B LARS1 MOB1A SPDYA RICTOR AGAP11 MAP3K12 ALK | 6.73e-04 | 656 | 89 | 10 | GO:0008047 |
| Domain | SLY | 6.56e-05 | 3 | 88 | 2 | PF12485 | |
| Domain | rSAM/SH3_domain-containing | 6.56e-05 | 3 | 88 | 2 | IPR021090 | |
| Domain | Mob1_phocein | 4.54e-04 | 7 | 88 | 2 | PF03637 | |
| Domain | MOB_kinase_act_fam | 4.54e-04 | 7 | 88 | 2 | IPR005301 | |
| Domain | - | 4.54e-04 | 7 | 88 | 2 | 1.20.140.30 | |
| Domain | Mob1_phocein | 4.54e-04 | 7 | 88 | 2 | SM01388 | |
| Domain | Myosin_head_motor_dom | 7.57e-04 | 38 | 88 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 7.57e-04 | 38 | 88 | 3 | PS51456 | |
| Domain | Myosin_head | 7.57e-04 | 38 | 88 | 3 | PF00063 | |
| Domain | MYSc | 7.57e-04 | 38 | 88 | 3 | SM00242 | |
| Domain | Myosin_N | 2.21e-03 | 15 | 88 | 2 | PF02736 | |
| Domain | Myosin_N | 2.21e-03 | 15 | 88 | 2 | IPR004009 | |
| Domain | AT_hook | 2.52e-03 | 16 | 88 | 2 | PF02178 | |
| Domain | Myosin_tail_1 | 3.20e-03 | 18 | 88 | 2 | PF01576 | |
| Domain | Myosin_tail | 3.20e-03 | 18 | 88 | 2 | IPR002928 | |
| Domain | ZINC_FINGER_C2H2_2 | SP1 ZNF705A ZNF138 ZNF469 ZNF609 ZNF516 ZBTB21 ZNF667 ZBTB11 ZNF512 | 3.47e-03 | 775 | 88 | 10 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | SP1 ZNF705A ZNF138 ZNF469 ZNF609 ZNF516 ZBTB21 ZNF667 ZBTB11 ZNF512 | 3.54e-03 | 777 | 88 | 10 | PS00028 |
| Domain | Myosin-like_IQ_dom | 3.56e-03 | 19 | 88 | 2 | IPR027401 | |
| Domain | - | 3.56e-03 | 19 | 88 | 2 | 4.10.270.10 | |
| Domain | Znf_C2H2-like | SP1 ZNF705A ZNF138 ZNF469 ZNF609 ZNF516 ZBTB21 ZNF667 ZBTB11 ZNF512 | 4.19e-03 | 796 | 88 | 10 | IPR015880 |
| Domain | Znf_C2H2 | SP1 ZNF705A ZNF138 ZNF469 ZNF609 ZNF516 ZBTB21 ZNF667 ZBTB11 ZNF512 | 4.53e-03 | 805 | 88 | 10 | IPR007087 |
| Domain | IQ | 4.59e-03 | 71 | 88 | 3 | PF00612 | |
| Domain | ZnF_C2H2 | SP1 ZNF705A ZNF138 ZNF469 ZNF609 ZNF516 ZBTB21 ZNF667 ZBTB11 ZNF512 | 4.65e-03 | 808 | 88 | 10 | SM00355 |
| Domain | Peptidase_M14 | 5.21e-03 | 23 | 88 | 2 | PF00246 | |
| Domain | Peptidase_M14 | 5.21e-03 | 23 | 88 | 2 | IPR000834 | |
| Domain | zf-C2H2 | SP1 ZNF705A ZNF138 ZNF469 ZNF516 ZBTB21 ZNF667 ZBTB11 ZNF512 | 5.31e-03 | 693 | 88 | 9 | PF00096 |
| Domain | Znf_PHD-finger | 6.18e-03 | 79 | 88 | 3 | IPR019787 | |
| Domain | IQ | 6.62e-03 | 81 | 88 | 3 | SM00015 | |
| Domain | SANT_dom | 6.63e-03 | 26 | 88 | 2 | IPR017884 | |
| Domain | AT_hook | 7.14e-03 | 27 | 88 | 2 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 7.14e-03 | 27 | 88 | 2 | IPR017956 | |
| Domain | SANT | 7.66e-03 | 28 | 88 | 2 | PS51293 | |
| Domain | IQ_motif_EF-hand-BS | 8.84e-03 | 90 | 88 | 3 | IPR000048 | |
| Domain | HMGI/Y_DNA-bd_CS | 9.34e-03 | 31 | 88 | 2 | IPR000637 | |
| Pubmed | TET2 RCOR1 MYH9 ZNF609 MAP7D1 MRTFB ZNF516 ZBTB21 ABCD3 APC ZBTB11 | 1.49e-08 | 418 | 92 | 11 | 34709266 | |
| Pubmed | 6.89e-08 | 486 | 92 | 11 | 20936779 | ||
| Pubmed | MYBBP1A MYH9 MAP7D1 MYH11 HMGA2 ANK2 UNCX STAG1 ABI3BP SACS ZBTB21 SRP72 ISG20L2 CAGE1 TTC3 ZBTB11 C2orf78 | 2.13e-07 | 1442 | 92 | 17 | 35575683 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 6.33e-07 | 370 | 92 | 9 | 22922362 | |
| Pubmed | TET2 ATXN7L3 SP1 MYBBP1A RCOR1 ZNF609 MAP7D1 EDC3 RRP1B ATAD5 ZNF516 ZBTB21 LARS1 ABCD3 SRP72 ZNF512 | 1.00e-06 | 1429 | 92 | 16 | 35140242 | |
| Pubmed | IVNS1ABP TET2 ZNF609 RRP1B SETBP1 ZNF516 ZBTB21 LARS1 AGAP11 KAT6B | 1.44e-06 | 529 | 92 | 10 | 14621295 | |
| Pubmed | ATXN7L3 MAP7D1 EDC3 MRTFB RRP1B ATAD5 INTS15 NFX1 ABCD3 ANKRD11 APC SRP72 RICTOR ISG20L2 ZBTB11 NSD3 | 1.84e-06 | 1497 | 92 | 16 | 31527615 | |
| Pubmed | MYBBP1A MYH9 EDC3 ANK2 MYO9A LARS1 ABCD3 APC SRP72 ROBO1 RICTOR | 2.78e-06 | 708 | 92 | 11 | 39231216 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | IVNS1ABP ARFGEF3 TET2 MAP7D1 EDC3 MYO9A ZBTB21 ANKRD11 APC RICTOR ARHGEF16 NSD3 | 2.90e-06 | 861 | 92 | 12 | 36931259 |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 30349003 | ||
| Pubmed | Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice. | 6.92e-06 | 2 | 92 | 2 | 23143302 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 26202160 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 30759861 | ||
| Pubmed | Human Mob1 proteins are required for cytokinesis by controlling microtubule stability. | 6.92e-06 | 2 | 92 | 2 | 22454515 | |
| Pubmed | Non-muscle myosin heavy chain (MYH9): a new partner fused to ALK in anaplastic large cell lymphoma. | 6.92e-06 | 2 | 92 | 2 | 12800156 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 30542210 | ||
| Pubmed | EGFR Regulates the Hippo pathway by promoting the tyrosine phosphorylation of MOB1. | 2.07e-05 | 3 | 92 | 2 | 34725466 | |
| Pubmed | The human tumour suppressor LATS1 is activated by human MOB1 at the membrane. | 2.07e-05 | 3 | 92 | 2 | 16674920 | |
| Pubmed | Histone deacetylase inhibition is associated with transcriptional repression of the Hmga2 gene. | 2.07e-05 | 3 | 92 | 2 | 12799440 | |
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 35128634 | ||
| Pubmed | MYBBP1A ANK2 RRP1B SACS ATAD5 ABCD3 ANKRD11 ROBO1 RICTOR TMEM131 TTC3 ZNF512 DNAJC6 DMXL1 | 3.56e-05 | 1487 | 92 | 14 | 33957083 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ATXN7L3 SP1 MYBBP1A RCOR1 MYH9 ZNF609 MAP7D1 RRP1B ATAD5 ANKRD11 ISG20L2 NKTR NSD3 | 3.59e-05 | 1294 | 92 | 13 | 30804502 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MYBBP1A MYH9 EDC3 MRTFB ANK2 ATAD5 ZBTB21 ZNF667 LARS1 ABCD3 PRR14L | 3.66e-05 | 934 | 92 | 11 | 33916271 |
| Pubmed | ATXN7L3 ZNF469 RCOR1 ZNF609 MAP7D1 KMT5B ATAD5 ZBTB21 RICTOR TRAF3IP3 KAT6B NSD3 | 3.84e-05 | 1116 | 92 | 12 | 31753913 | |
| Pubmed | PTEN-GSK3β-MOB1 axis controls neurite outgrowth in vitro and in vivo. | 4.14e-05 | 4 | 92 | 2 | 30069702 | |
| Pubmed | 4.14e-05 | 4 | 92 | 2 | 25605242 | ||
| Pubmed | Mechanism of activation of NDR (nuclear Dbf2-related) protein kinase by the hMOB1 protein. | 4.14e-05 | 4 | 92 | 2 | 15197186 | |
| Pubmed | 4.14e-05 | 4 | 92 | 2 | 29932067 | ||
| Pubmed | 4.14e-05 | 4 | 92 | 2 | 33452460 | ||
| Pubmed | 4.14e-05 | 4 | 92 | 2 | 23302812 | ||
| Pubmed | 6.11e-05 | 655 | 92 | 9 | 35819319 | ||
| Pubmed | Docking motif-guided mapping of the interactome of protein phosphatase-1. | 6.22e-05 | 80 | 92 | 4 | 19389623 | |
| Pubmed | A gene expression map of human chromosome 21 orthologues in the mouse. | 6.49e-05 | 158 | 92 | 5 | 12466855 | |
| Pubmed | MRTFB suppresses colorectal cancer development through regulating SPDL1 and MCAM. | 6.89e-05 | 5 | 92 | 2 | 31690663 | |
| Pubmed | YAP1 is a potent driver of the onset and progression of oral squamous cell carcinoma. | 6.89e-05 | 5 | 92 | 2 | 32206709 | |
| Pubmed | Induction of intestinal stem cells by R-spondin 1 and Slit2 augments chemoradioprotection. | 6.89e-05 | 5 | 92 | 2 | 23903657 | |
| Pubmed | Telokin expression is restricted to smooth muscle tissues during mouse development. | 6.89e-05 | 5 | 92 | 2 | 11121372 | |
| Pubmed | 7.53e-05 | 163 | 92 | 5 | 12466854 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 8.70e-05 | 394 | 92 | 7 | 27248496 | |
| Pubmed | 1.03e-04 | 6 | 92 | 2 | 17183527 | ||
| Pubmed | 1.03e-04 | 6 | 92 | 2 | 35858357 | ||
| Pubmed | 1.03e-04 | 6 | 92 | 2 | 25476526 | ||
| Pubmed | 1.03e-04 | 6 | 92 | 2 | 17244818 | ||
| Pubmed | Endogenous YAP1 activation drives immediate onset of cervical carcinoma in situ in mice. | 1.03e-04 | 6 | 92 | 2 | 32716083 | |
| Pubmed | 1.03e-04 | 6 | 92 | 2 | 25103237 | ||
| Pubmed | YAP determines the cell fate of injured mouse hepatocytes in vivo. | 1.03e-04 | 6 | 92 | 2 | 28681838 | |
| Pubmed | 1.11e-04 | 177 | 92 | 5 | 26206133 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 1.30e-04 | 724 | 92 | 9 | 36232890 | |
| Pubmed | 1.35e-04 | 568 | 92 | 8 | 37774976 | ||
| Pubmed | MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation. | 1.44e-04 | 7 | 92 | 2 | 18328708 | |
| Pubmed | Purification of the Prep1 interactome identifies novel pathways regulated by Prep1. | 1.44e-04 | 7 | 92 | 2 | 17623278 | |
| Pubmed | ZNF516 suppresses EGFR by targeting the CtBP/LSD1/CoREST complex to chromatin. | 1.44e-04 | 7 | 92 | 2 | 28947780 | |
| Pubmed | TET2 ANK2 STAG1 SACS LARS1 NAV3 APC ROBO1 TMEM131 HUNK TTC3 ZBTB11 | 1.46e-04 | 1285 | 92 | 12 | 35914814 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ARFGEF3 ZNF609 USF3 MRTFB KCNH8 MYO9A SETBP1 ANKRD11 KAT6B TTC3 ZNF512 ARHGEF16 MAP3K12 | 1.48e-04 | 1489 | 92 | 13 | 28611215 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.49e-04 | 430 | 92 | 7 | 35044719 | |
| Pubmed | 1.53e-04 | 39 | 92 | 3 | 25825154 | ||
| Pubmed | Interactome study suggests multiple cellular functions of hepatoma-derived growth factor (HDGF). | 1.58e-04 | 191 | 92 | 5 | 21907836 | |
| Pubmed | Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. | 1.60e-04 | 102 | 92 | 4 | 15778465 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 1.72e-04 | 440 | 92 | 7 | 34244565 | |
| Pubmed | A protein interaction network for pluripotency of embryonic stem cells. | 1.78e-04 | 41 | 92 | 3 | 17093407 | |
| Pubmed | An integrated workflow for charting the human interaction proteome: insights into the PP2A system. | 1.79e-04 | 105 | 92 | 4 | 19156129 | |
| Pubmed | Hundreds of variants clustered in genomic loci and biological pathways affect human height. | 1.87e-04 | 198 | 92 | 5 | 20881960 | |
| Pubmed | Proteome-wide analysis of phospho-regulated PDZ domain interactions. | 1.91e-04 | 42 | 92 | 3 | 30126976 | |
| Pubmed | 1.92e-04 | 8 | 92 | 2 | 19739119 | ||
| Pubmed | The leukotriene receptors as therapeutic targets of inflammatory diseases. | 1.92e-04 | 8 | 92 | 2 | 31135881 | |
| Pubmed | Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice. | 1.92e-04 | 8 | 92 | 2 | 26699479 | |
| Pubmed | 1.92e-04 | 8 | 92 | 2 | 23240041 | ||
| Pubmed | 1.92e-04 | 8 | 92 | 2 | 33424621 | ||
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 1.99e-04 | 316 | 92 | 6 | 31665637 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 2.14e-04 | 608 | 92 | 8 | 36089195 | |
| Pubmed | 2.19e-04 | 44 | 92 | 3 | 25010285 | ||
| Pubmed | 2.20e-04 | 777 | 92 | 9 | 35844135 | ||
| Pubmed | MYBBP1A RCOR1 MYH9 MAP7D1 ANK2 ZNF516 ZBTB21 APC TTC3 DNAJC6 | 2.35e-04 | 963 | 92 | 10 | 28671696 | |
| Pubmed | 2.40e-04 | 209 | 92 | 5 | 36779422 | ||
| Pubmed | 2.46e-04 | 210 | 92 | 5 | 16565220 | ||
| Pubmed | 2.46e-04 | 9 | 92 | 2 | 26829768 | ||
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 2.51e-04 | 330 | 92 | 6 | 33301849 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 2.74e-04 | 475 | 92 | 7 | 31040226 | |
| Pubmed | 3.03e-04 | 483 | 92 | 7 | 36912080 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 3.63e-04 | 498 | 92 | 7 | 36634849 | |
| Pubmed | 3.86e-04 | 503 | 92 | 7 | 16964243 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 3.87e-04 | 358 | 92 | 6 | 32460013 | |
| Pubmed | MYBBP1A MYH9 MAP7D1 MYH11 ANK2 SACS MYO9A LARS1 ABCD3 APC SRP72 DNAJC6 | 3.90e-04 | 1431 | 92 | 12 | 37142655 | |
| Pubmed | 3.92e-04 | 129 | 92 | 4 | 23563607 | ||
| Pubmed | 3.96e-04 | 233 | 92 | 5 | 37704626 | ||
| Pubmed | 4.03e-04 | 54 | 92 | 3 | 22266860 | ||
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 4.12e-04 | 235 | 92 | 5 | 30258100 | |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | 4.22e-04 | 364 | 92 | 6 | 24778252 | |
| Pubmed | CHD4 and the NuRD complex directly control cardiac sarcomere formation. | 4.49e-04 | 12 | 92 | 2 | 29891665 | |
| Pubmed | 4.49e-04 | 12 | 92 | 2 | 8424456 | ||
| Pubmed | IL-7Rα glutamylation and activation of transcription factor Sall3 promote group 3 ILC development. | 4.49e-04 | 12 | 92 | 2 | 28794449 | |
| Pubmed | MYBBP1A ZNF609 RRP1B ATAD5 ABCD3 MOB1A ROBO1 RICTOR ZNF512 NSD3 | 4.60e-04 | 1049 | 92 | 10 | 27880917 | |
| Pubmed | 4.92e-04 | 689 | 92 | 8 | 36543142 | ||
| Pubmed | 4.97e-04 | 58 | 92 | 3 | 24144296 | ||
| Pubmed | 4.97e-04 | 245 | 92 | 5 | 35652658 | ||
| Pubmed | Genome-wide and candidate gene association study of cigarette smoking behaviors. | 5.30e-04 | 13 | 92 | 2 | 19247474 | |
| Pubmed | An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. | 5.30e-04 | 13 | 92 | 2 | 16079794 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 5.44e-04 | 533 | 92 | 7 | 30554943 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 5.63e-04 | 536 | 92 | 7 | 15840001 | |
| Pubmed | 5.75e-04 | 538 | 92 | 7 | 10512203 | ||
| Interaction | H3C1 interactions | MYBBP1A RCOR1 MYH9 MAP7D1 HMGA2 ANK2 STAG1 RRP1B ATAD5 NAV3 SRP72 PRR14L KAT6B ZNF512 NSD3 | 1.16e-05 | 901 | 91 | 15 | int:H3C1 |
| Interaction | YWHAH interactions | IVNS1ABP ARFGEF3 TET2 MAP7D1 MYH11 EDC3 MYO9A ZBTB21 MOB1A ANKRD11 APC RICTOR NKTR SAMSN1 ARHGEF16 NSD3 | 3.09e-05 | 1102 | 91 | 16 | int:YWHAH |
| Interaction | HDAC1 interactions | TET2 SP1 MYBBP1A RCOR1 MYH9 ZNF609 MAP7D1 MRTFB STAG1 ZNF516 ZBTB21 ABCD3 APC SAMSN1 ZBTB11 DNAJC6 | 3.30e-05 | 1108 | 91 | 16 | int:HDAC1 |
| Interaction | PKNOX1 interactions | 3.49e-05 | 82 | 91 | 5 | int:PKNOX1 | |
| Interaction | KLF15 interactions | 5.05e-05 | 290 | 91 | 8 | int:KLF15 | |
| Interaction | TNFRSF1B interactions | 5.24e-05 | 146 | 91 | 6 | int:TNFRSF1B | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q12 | 1.79e-04 | 54 | 92 | 3 | chr3q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p23 | 2.39e-04 | 149 | 92 | 4 | chr2p23 | |
| Cytoband | 2p23 | 5.30e-04 | 17 | 92 | 2 | 2p23 | |
| GeneFamily | SAM and SH3 domain containing|Sterile alpha motif domain containing | 3.69e-05 | 3 | 64 | 2 | 731 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | SP1 ZNF705A ZNF138 ZNF469 ZNF609 ZNF516 ZBTB21 ZNF667 ZBTB11 ZNF512 | 1.99e-04 | 718 | 64 | 10 | 28 |
| GeneFamily | MOB kinase activators|STRIPAK complex | 2.56e-04 | 7 | 64 | 2 | 647 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 4.50e-04 | 181 | 64 | 5 | 694 | |
| GeneFamily | Myosin heavy chains | 1.26e-03 | 15 | 64 | 2 | 1098 | |
| GeneFamily | PHD finger proteins | 3.99e-03 | 90 | 64 | 3 | 88 | |
| Coexpression | GSE3982_MAC_VS_BCELL_DN | 5.37e-06 | 197 | 90 | 7 | M5495 | |
| Coexpression | GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_DN | 5.74e-06 | 199 | 90 | 7 | M3175 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_top-relative-expression-ranked_200 | 6.19e-05 | 162 | 89 | 6 | gudmap_developingKidney_e15.5_S-shaped body_200 | |
| CoexpressionAtlas | ratio_EmbryoidBody-blastocyst_vs_EmbryoidBody-fibro_top-relative-expression-ranked_2500_k-means-cluster#1 | XYLT1 ATXN7L3 MIS18BP1 EDC3 RETREG2 ATAD5 INTS15 ZNF667 MOB1A ISG20L2 TRAF3IP3 SAMSN1 AGBL5 TRMT2B | 6.31e-05 | 993 | 89 | 14 | ratio_EB-blastocyst_vs_EB-fibro_2500_K1 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | DDIAS LUZP4 MYBBP1A MIS18BP1 UNCX ST3GAL6 ATAD5 SETBP1 LPIN2 ROBO1 HUNK CDH4 | 6.69e-05 | 749 | 89 | 12 | gudmap_kidney_P3_CapMes_Crym_1000 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.18e-04 | 114 | 89 | 5 | gudmap_kidney_P4_CapMesRenVes_Crym_k4_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#4_top-relative-expression-ranked_100 | 1.19e-04 | 23 | 89 | 3 | gudmap_developingKidney_e15.5_Podocyte cells_100_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | DDIAS MAP7D1 HMGA2 ATAD5 MOB1B APC TMEM131 PARPBP ZBTB11 MAP3K12 | 1.25e-04 | 564 | 89 | 10 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#1_top-relative-expression-ranked_500 | 1.25e-04 | 61 | 89 | 4 | gudmap_kidney_P4_CapMesRenVes_Crym_k1_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#3_top-relative-expression-ranked_100 | 1.72e-04 | 5 | 89 | 2 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_100_k3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-06 | 170 | 92 | 6 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-06 | 182 | 92 | 6 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.60e-06 | 188 | 92 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.76e-06 | 190 | 92 | 6 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-06 | 192 | 92 | 6 | 03dcd9405d3d76fc7455066ba5d83c09cd17072d | |
| ToppCell | IPF-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 3.12e-06 | 194 | 92 | 6 | e8a9005963704286bcc50785bda8d7d63ec001b1 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.71e-06 | 200 | 92 | 6 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.76e-05 | 155 | 92 | 5 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.59e-05 | 168 | 92 | 5 | 6a233045638cb83dab64789b996b7598c325001e | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.82e-05 | 171 | 92 | 5 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.23e-05 | 176 | 92 | 5 | 581d78811b2d99f38a2c7cc268aeb1cf932379c2 | |
| ToppCell | facs-MAT-Fat-3m-Lymphocytic-T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-05 | 176 | 92 | 5 | 71b3309ddadd035a1224fca4fc5946dc4c0283fe | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-05 | 179 | 92 | 5 | 55bc69f107fc710db7617c428575792adfdbbcc1 | |
| ToppCell | NS-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.50e-05 | 179 | 92 | 5 | 65a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.69e-05 | 181 | 92 | 5 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.69e-05 | 181 | 92 | 5 | 7f99002a6411117cc2361334c7c9228e20c574b4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.89e-05 | 183 | 92 | 5 | 83592c332b1e82673f993d37c7f480befdc3dcda | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.99e-05 | 184 | 92 | 5 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.31e-05 | 187 | 92 | 5 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 4.31e-05 | 187 | 92 | 5 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.42e-05 | 188 | 92 | 5 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | IPF-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 4.54e-05 | 189 | 92 | 5 | 5c22d2d935f7bb270260b8bc6be67b565ec401bf | |
| ToppCell | COPD-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 4.65e-05 | 190 | 92 | 5 | aece860b5609ad5a8fc920d685f0d0ec71bf9018 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.65e-05 | 190 | 92 | 5 | 1cf023e3c6924d6a06f353d4b62444b6f2fee8a7 | |
| ToppCell | COPD-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 4.65e-05 | 190 | 92 | 5 | ed978cd5d9da87b49878a330e362762c487f849f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.65e-05 | 190 | 92 | 5 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 4.65e-05 | 190 | 92 | 5 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.77e-05 | 191 | 92 | 5 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_mast/basophil_(18)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.77e-05 | 191 | 92 | 5 | 14b11244c330cc4fe897253aaaf0df80caa01a55 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.77e-05 | 191 | 92 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.89e-05 | 192 | 92 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.89e-05 | 192 | 92 | 5 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.89e-05 | 192 | 92 | 5 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.01e-05 | 193 | 92 | 5 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.01e-05 | 193 | 92 | 5 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Control-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 5.01e-05 | 193 | 92 | 5 | 3479c01aaae7afd7e02d00e0cb21951c0106a0fd | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 5.01e-05 | 193 | 92 | 5 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.01e-05 | 193 | 92 | 5 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.01e-05 | 193 | 92 | 5 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 5.14e-05 | 194 | 92 | 5 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.14e-05 | 194 | 92 | 5 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.26e-05 | 195 | 92 | 5 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | E17.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.26e-05 | 195 | 92 | 5 | 1daddd801bd4596fffbdb822fc326d5127c96004 | |
| ToppCell | Control-Myeloid-ncMonocyte|Control / Disease state, Lineage and Cell class | 5.26e-05 | 195 | 92 | 5 | fcb05948e7480dc53f06f3fc9b9c3fc129874edd | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.39e-05 | 196 | 92 | 5 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 5.39e-05 | 196 | 92 | 5 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.52e-05 | 197 | 92 | 5 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.52e-05 | 197 | 92 | 5 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | 5.52e-05 | 197 | 92 | 5 | 038fd92750257d43d5e980fd06d77742b543f11a | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 5.66e-05 | 198 | 92 | 5 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 5.66e-05 | 198 | 92 | 5 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.66e-05 | 198 | 92 | 5 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.79e-05 | 199 | 92 | 5 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 5.79e-05 | 199 | 92 | 5 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.79e-05 | 199 | 92 | 5 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 5.79e-05 | 199 | 92 | 5 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.79e-05 | 199 | 92 | 5 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.79e-05 | 199 | 92 | 5 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.79e-05 | 199 | 92 | 5 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.93e-05 | 200 | 92 | 5 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.72e-04 | 134 | 92 | 4 | 8a3acf32cabc37b49d6488d43cdaae7cec79d119 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Acta2Rgs5.Rgs5_(Mural.Acta2Rgs5.Rgs5)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.72e-04 | 134 | 92 | 4 | 1fa13185a4dfb4563473184c0c4f449011d88631 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Acta2Rgs5.Rgs5_(Mural.Acta2Rgs5.Rgs5)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.72e-04 | 134 | 92 | 4 | 1ab99a22d0d7657f62f8ea7d96bb24e88de54fd4 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.77e-04 | 135 | 92 | 4 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | Endothelial-Endothelial-H_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | 1.92e-04 | 138 | 92 | 4 | a1f41a5a9da40adcc343722baef78c603599c3f0 | |
| ToppCell | LPS_only-Hematopoietic_Mast-Mast_cells-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.64e-04 | 150 | 92 | 4 | ccb782fbcb3122266354a112a9a850506664f44d | |
| ToppCell | Severe-B_naive-5|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.85e-04 | 153 | 92 | 4 | 44572f87d403e314050ab935d2cd676c33d9c287 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.92e-04 | 154 | 92 | 4 | 1f8d127b657976656e4ec292f26d619943533b86 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.07e-04 | 156 | 92 | 4 | dd41ed918b07fa248da458a629b3c53cb7ea8764 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.07e-04 | 156 | 92 | 4 | 0f54d62c0fc08bbdd5ac743b2d5d748c3d1e6ef9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.07e-04 | 156 | 92 | 4 | abf9dd075b1ca8f613c660cc82f8a5af071fb6ab | |
| ToppCell | Severe-B_naive-5|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.14e-04 | 157 | 92 | 4 | a57ee4a6febdff3ee3d1645836695e6e7c055cf8 | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.29e-04 | 159 | 92 | 4 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-04 | 161 | 92 | 4 | a7e74bc80ac11250e353e5614b19c05793fc2e95 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.54e-04 | 162 | 92 | 4 | 3f264263878af630921911c2b344ac56eb1e7099 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nxph3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.61e-04 | 67 | 92 | 3 | b80bdd122a0284611161c40ec7a9c893dc8de4de | |
| ToppCell | normal-na-Lymphocytic_T-T4_reg-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.62e-04 | 163 | 92 | 4 | 43887e7687fc6367efac0c1f56a9534b06f47b7f | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_1|COVID-19_Mild / Disease condition and Cell class | 3.79e-04 | 165 | 92 | 4 | ef709c5d3231c65d351316e1e31b9c9eba721628 | |
| ToppCell | PCW_07-8.5-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_mast/basophil_(18)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.88e-04 | 166 | 92 | 4 | f03f78cae6272c89618c0bda032ce45c4fc96baa | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Biphasic|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 3.97e-04 | 167 | 92 | 4 | 9062577a4b7902c9a888d706589d1b05221c0fa8 | |
| ToppCell | PCW_07-8.5-Immune_Lymphocytic-Immune_Lymphocytic_B-im_B_cell_(15)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.06e-04 | 168 | 92 | 4 | 2ec53f91de3bff8a106430a78b81ee6870f0c55e | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.06e-04 | 168 | 92 | 4 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.06e-04 | 168 | 92 | 4 | 2fb2d916eb5000a637240d38e47a9b4f61f9f83f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.06e-04 | 168 | 92 | 4 | 2572a3dd4f3f619bd26a3cd6e60de43821d8bb64 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_1|Classical_Monocyte / Disease condition and Cell class | 4.06e-04 | 168 | 92 | 4 | d50078614f7af74dc2aa4081c1708a5156ac51cf | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.15e-04 | 169 | 92 | 4 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.15e-04 | 169 | 92 | 4 | cfc9ff103d13a2d5eacc457e800f53fdd29f7738 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.24e-04 | 170 | 92 | 4 | 32917888c3f1d54302675c1d4de1fd3b7c79af5f | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.34e-04 | 171 | 92 | 4 | eddc5e05003382603ee49f74b9e2242a43021096 | |
| ToppCell | facs-Heart-RV-18m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-04 | 172 | 92 | 4 | d061ea21bee179df5a525842e9a48621a8e1461b | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 173 | 92 | 4 | c31076c725f4cd912c56903592a2d9356ae59f54 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 173 | 92 | 4 | f38bf7584e08d15a6e2c116b7c3551ba475a5e14 | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 4.53e-04 | 173 | 92 | 4 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 173 | 92 | 4 | a4ed191cfdf6588b7f3672995bf0a4fe9e4b8df6 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.53e-04 | 173 | 92 | 4 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.63e-04 | 174 | 92 | 4 | 46bd0ef7d0541386de7a901d85d53d0176dc92bf | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-04 | 175 | 92 | 4 | d2ff8fedca9039cbd45cfd9dec88f4edbe7fe4fc | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_1|Classical_Monocyte / Disease condition and Cell class | 4.73e-04 | 175 | 92 | 4 | 35ea2ed93538e6bf803029fcf7d9243f93e7733d | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-04 | 175 | 92 | 4 | a7310950e8d51b3004ea3aee8ce9948fe8655112 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.73e-04 | 175 | 92 | 4 | 15c69dd5635c9251c535f1e22467712e9667ae92 | |
| Disease | carotid plaque build | 1.19e-04 | 84 | 88 | 4 | EFO_0006501 | |
| Disease | leiomyoma (is_implicated_in) | 1.31e-04 | 6 | 88 | 2 | DOID:127 (is_implicated_in) | |
| Disease | Neurodevelopmental Disorders | 1.76e-04 | 93 | 88 | 4 | C1535926 | |
| Disease | Methionine sulfoxide measurement | 5.69e-04 | 12 | 88 | 2 | EFO_0021650 | |
| Disease | gallbladder cancer (is_implicated_in) | 6.71e-04 | 13 | 88 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | mean platelet volume | TET2 LUZP4 RCOR1 MYH9 MYH11 EDC3 ST3GAL6 ATAD5 SETBP1 ANKRD11 | 9.18e-04 | 1020 | 88 | 10 | EFO_0004584 |
| Disease | Colorectal Carcinoma | 1.19e-03 | 702 | 88 | 8 | C0009402 | |
| Disease | axial length measurement | 1.60e-03 | 77 | 88 | 3 | EFO_0005318 | |
| Disease | Leukemia, Myelocytic, Acute | 1.81e-03 | 173 | 88 | 4 | C0023467 | |
| Disease | diffuse plaque measurement | 1.93e-03 | 758 | 88 | 8 | EFO_0010699 | |
| Disease | platelet crit | 2.14e-03 | 952 | 88 | 9 | EFO_0007985 | |
| Disease | Glioma | 2.27e-03 | 87 | 88 | 3 | C0017638 | |
| Disease | central corneal thickness | 2.35e-03 | 309 | 88 | 5 | EFO_0005213 | |
| Disease | mean reticulocyte volume | 2.67e-03 | 799 | 88 | 8 | EFO_0010701 | |
| Disease | mean fractional anisotropy measurement | 2.91e-03 | 95 | 88 | 3 | EFO_0008399 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VNKKRGLRTPPKSHN | 611 | Q8NDL9 | |
| SPTALKHPEKNQKKL | 756 | Q96QE3 | |
| HSPLKKKRNASPNKD | 96 | Q5JX71 | |
| LSPLKGPKKNKHSQI | 911 | Q8NEM8 | |
| KLNLPPSPHANKKKH | 236 | Q8TF27 | |
| KARKPRSKSLENHPK | 746 | Q8TC20 | |
| GLKHKAKNPEPQKAT | 326 | Q6UB99 | |
| KNKHKASEPIQGAPK | 501 | A6NCI8 | |
| QPHTRSPAKNKKTLG | 186 | Q5VV41 | |
| NKKNKKSRGPTRPSN | 176 | B4E2M5 | |
| PHKNCRKNTTVPGKK | 16 | Q8N535 | |
| IKQSNSSSGLHPPKK | 1266 | Q9Y485 | |
| PNSPRRSKSLKHKNG | 161 | Q14CW9 | |
| HSTQAKNRAKRKPPK | 301 | Q9UKL0 | |
| NEPPQHKNAKIPKKS | 526 | Q9NWS1 | |
| RKKKPPLSNGHVSNK | 256 | Q96N11 | |
| GNHDKKPSQKPSGFK | 86 | Q9P127 | |
| KPVLRKAFQHQPGKK | 1186 | Q8WYB5 | |
| QKQHKPSLGIKKPVR | 1691 | Q01484 | |
| NKKHGVFSKLPRNPK | 276 | Q3ZCV2 | |
| PRGKGSQKHVTKKKP | 926 | Q6P0N0 | |
| KKPPRENGHKQISSS | 256 | Q9Y6Y0 | |
| ASPKHQKKSKLHGPT | 306 | P20138 | |
| HINNSRVPKKLKKPA | 431 | Q4FZB7 | |
| LAPPKAGSKNLSNKK | 446 | Q8IVL0 | |
| PRKKLKHIRQGTNKG | 901 | Q8IXT1 | |
| KQSHPKNPNDKHRSK | 266 | Q9ULH7 | |
| LSKKNQPPSKAPKLH | 41 | Q9H9L3 | |
| VNKGKNSKKSHSFPP | 1011 | Q12986 | |
| GTHPKFQKPKQLKDK | 551 | P35579 | |
| KTFKPKKNIPEGSHQ | 11 | Q7L9L4 | |
| SRHPNQATPKKSGLK | 166 | Q96F86 | |
| NKKHRSSSDPKGGKL | 1106 | Q6R327 | |
| IKNSKHNTPRKKTNP | 281 | P51956 | |
| QHQKALPKKGVLGKS | 1276 | Q9BQG0 | |
| NPHGPREKKAKVGSK | 361 | P36383 | |
| NHKNSLKSPAIPEGK | 531 | Q5TH69 | |
| SVNKMNKPGKHRKTP | 81 | Q5TBE3 | |
| NKPGKHRKTPSPKIN | 86 | Q5TBE3 | |
| RPFSKKLDKNLPSHK | 451 | P57058 | |
| KLDKNLPSHKQPSGS | 456 | P57058 | |
| NGDKPHGVKKPSKKQ | 471 | O75061 | |
| HGVKKPSKKQQEPAA | 476 | O75061 | |
| HKPQKGKKVVALDPS | 131 | P55283 | |
| KKRNVPQKLSPHSKR | 491 | Q12852 | |
| PPTKQEVKKAGERHK | 126 | Q3KQU3 | |
| RPKGSKNKSPSKAAQ | 51 | P52926 | |
| QSKGKRPKPKTLHEL | 246 | O75995 | |
| KHQSPKKLKVNSLPE | 4291 | Q9NZJ4 | |
| VPPKNAKAKIDATHK | 3136 | Q6ZTR5 | |
| SDNSSPQPLKRKGKK | 266 | Q9UHG0 | |
| AKKGVLPLKKQPHRT | 1511 | Q5THK1 | |
| GSNRSHQPKKPITLK | 21 | Q5MJ70 | |
| QKGQKSQKKPSHLGP | 61 | Q96GJ1 | |
| RKKKKKHHLQPENPG | 401 | Q14684 | |
| QDPLHSPTSKRKKVK | 1041 | Q8N3T6 | |
| RGKPQKHKHGSKENL | 971 | P30414 | |
| HPRTKKDPSKTNKLI | 251 | Q8NE09 | |
| KGKKTDKQPLQKPSH | 921 | Q9P2J5 | |
| PSNVSEKEKHQKPKR | 6 | Q9NSI8 | |
| KTFKPKKNIPEGSHQ | 11 | Q9H8S9 | |
| HKHDKRKRQGKNAPP | 256 | Q8NC44 | |
| KVFPKNQKPKHPTTG | 246 | Q9Y274 | |
| HQKPAGAPATKKKQQ | 646 | O76094 | |
| LSKHIKTHQNKKGGP | 701 | P08047 | |
| HGKKSGKPPLQNNEK | 36 | P28288 | |
| TKKNNPIAKKEPHDR | 1516 | Q9UM73 | |
| KKPSRLKGDNEKHSP | 2051 | P25054 | |
| LKSALRKGHPQKAKT | 316 | Q9NS75 | |
| RKGHPQKAKTKCVFP | 321 | Q9NS75 | |
| EQGSHPKFQKPKQLK | 556 | P35749 | |
| NKNSVLVKPKKGHSG | 126 | Q5HYK9 | |
| GPHRIKATNNKGKEK | 286 | Q16881 | |
| IKKPPKHHRGTQTKA | 156 | Q9Y228 | |
| KAHGPKTGSKNRPKS | 296 | Q92618 | |
| RTQKQKHQPELAKKP | 171 | Q86Y38 | |
| KHQPELAKKPPSRQK | 176 | Q86Y38 | |
| KPLGVNKVAKPKEHA | 696 | Q9ULJ3 | |
| SKHFKKHQPKPEVRG | 751 | O95625 | |
| KSQKGRNHPDFPKRL | 96 | P0CB48 | |
| LFSPKPHKQIHTKGK | 156 | Q6ZN79 | |
| TNLSKPKKIHTGEKP | 151 | P52744 | |
| DPKIKQPNGSKHKLT | 1631 | Q92545 | |
| KASPSSANKRKNKPL | 431 | O15014 | |
| PSSQPPKHKGKQKSR | 431 | P53804 | |
| KTSSVRNKKGRPPLH | 1071 | Q8WVM7 | |
| NKKPGGRKHLAANKS | 796 | Q68DE3 | |
| QKTRPAKKLKHQPGH | 1456 | Q9Y6N7 | |
| NSRKPPPYKHIKANK | 1066 | Q9BZ95 | |
| PSHSEGKSNKKRGKL | 2596 | Q96JG9 | |
| AQKLPKGKRPNLKVH | 21 | Q7Z7G0 | |
| IKAPSLDPTNHKRKK | 406 | Q9Y6X0 | |
| PQKSHGKKVKREPAE | 1941 | Q6N021 | |
| QFQKVKPPKTNHKRG | 551 | Q96ME7 | |
| RKKENTKKGPGRPAH | 161 | A6NJT0 | |
| KTKQEIDPPNHNKRK | 776 | Q96L42 | |
| SKKKGVHKRSQHQGP | 386 | Q92539 | |
| TRNKNFKSKPALPKH | 841 | B2RTY4 | |
| LHKKKKPPSISAQFQ | 881 | B2RTY4 |